Review



powder x ray diffraction pxrd data analyses  (Rigaku Corporation)


Bioz Verified Symbol Rigaku Corporation is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Rigaku Corporation powder x ray diffraction pxrd data analyses
    Powder X Ray Diffraction Pxrd Data Analyses, supplied by Rigaku Corporation, used in various techniques. Bioz Stars score: 99/100, based on 40912 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/data+analyses/MiniFlex/pmc13006799-41-0-10
    Average 99 stars, based on 40912 article reviews
    powder x ray diffraction pxrd data analyses - by Bioz Stars, 2026-10
    99/100 stars

    Images

    Related Articles

    Produced:

    Article Title: Phyto-assisted synthesis and characterization of zinc oxide nanoparticles and zinc oxide copper composite nanoparticles using Curly Blumea ( Laggera crispata ) leaf extract and evaluation of their antibacterial activity
    Article Snippet: .. Using Ni-filtered CuKα (λ = 0.154060 nm) radiation and a powder X-ray diffractometer (Miniflex 600, Rigaku Corporation, Japan), the crystalline nature and particle size of the produced samples were assessed. ..

    X-ray Diffraction:

    Article Title: Biochemical Modulation of Fe 2 O 3 /CuFe 2 O 4 Nanocomposite via Two‐Stage Calcination: Antimicrobial Efficacy and In Vivo Toxicological Profiling
    Article Snippet: .. X‐ray diffraction (XRD) analysis was carried out using a Rigaku MiniFlex diffractometer (Rigaku Corporation, Tokyo, Japan) with Cu Kα radiation ( λ = 1.5406 Å). ..

    Article Title: Atomically Dispersed Fe‐Modified SnS for Sn‐Centered Peroxymonosulfate Activation Toward Acetaminophen Degradation
    Article Snippet: .. X‐ray powder diffraction (XRD, Rigaku MiniFlex 600) was implemented to confirm the crystal structure with 2‐theta degree from 20 to 80 at 40 kV and 15 mA. .. The morphology and structure of samples were analyzed by an Ultra‐High‐Resolution Schottky Scanning Electron Microscope (SEM, Hitachi SU7000) and the Spherical Aberration Corrected Transmission Electron Microscopy (TEM, Titan Themis FEI) at an acceleration voltage of 200 kV.

    Article Title: Sustainable upcycling of ABS plastic waste into nanostructured carbon for lithium-ion battery applications
    Article Snippet: Scanning electron microscopy (SEM, JSM IT800, JEOL) and transmission electron microscopy (TEM, JEM-1400Plus, JEOL) were employed to observe the surface morphology and microstructural features. .. The phase composition and structural ordering were assessed using an X-ray diffractometer (XRD, Rigaku MiniFlex) with an Ni-filtered Cu Kα radiation ( λ = 1.5406 Å). .. The interlayer distance ( d 002 ), crystallite height ( L c ), and average number of graphene layers ( N ) were calculated from the diffraction peaks of the (002) plane using the Bragg's law and Scherrer equation.

    Article Title: HATP ligand-engineered Co-MOF-74 synthesized by dielectric barrier discharge microplasma and its application in electrochemical sensing of p-benzoquinone in water samples.
    Article Snippet: p-Benzoquinone (PBQ), as a key toxic derivative of benzene, is widely present in industrial wastewater and the production and manufacturing of daily chemicals.. Long-term exposure poses a serious health threat, making the development of rapid and sensitive on-site detection technologies highly significant.. Electrochemical methods, due to their simple operation, high sensitivity, and ease of miniaturization, are an ideal approach for detecting PBQ.

    Analysis:

    Article Title: Biochemical Modulation of Fe 2 O 3 /CuFe 2 O 4 Nanocomposite via Two‐Stage Calcination: Antimicrobial Efficacy and In Vivo Toxicological Profiling
    Article Snippet: .. X‐ray diffraction (XRD) analysis was carried out using a Rigaku MiniFlex diffractometer (Rigaku Corporation, Tokyo, Japan) with Cu Kα radiation ( λ = 1.5406 Å). ..

    other:

    Article Title: Long-term evolution of Fe oxyhydroxide mineralogy and potentially toxic element partitioning in mining-impacted sediments of the Lower Doce River fluvial–estuarine system
    Article Snippet: Mineralogical characterization was performed by X-ray diffraction (XRD; Rigaku Miniflex 600C) using CuKα radiation operated at 40 kV and 15 mA, with data collected in continuous scan mode.

    Article Title: Interfacial synergy in a CoS 2 /Ketjen black hybrid electrode enabling electrochemical detection of sertraline hydrochloride.
    Article Snippet: A hybrid electrode integrating cobalt disulfide (CoS2) nanosheets with high-surface-area Ketjen black (KB) was developed for the electrochemical detection of sertraline hydrochloride (SER), a widely prescribed antidepressant increasingly found as an environmental contaminant.. CoS2 nanosheets synthesized hydrothermally at 180 °C exhibited well-defined crystalline features and a nanosheet morphology confirmed via detailed characterizations.. The incorporation of KB provided enhanced conductivity and active interfacial sites, yielding a synergistic hybrid surface with improved electron transfer kinetics.

    Article Title: PNIPAM-functionalized LDH-La alginate hydrogel beads as a high-capacity and recyclable adsorbent for phosphate capture.
    Article Snippet: Phosphate-induced eutrophication has become a severe environmental issue, urging the development of highperformance adsorbents for complex water treatment.. A hierarchical porous hydrogel bead LDHLa@PNIPAM/SA was constructed by compositing La3+-intercalated layered double hydroxide (LDH) into thermo-responsive poly(N-isopropylacrylamide)/sodium alginate network.. The eggshell-like porous structure and PNIPAM effectively accelerate ion diffusion and overcome mass transfer resistance; La3+ confinement in LDH interlayers drastically reduces metal leaching and enables reversible desorption for recyclable use.



    Similar Products

    86
    Nonlinear Dynamics surrogate data analyses
    Surrogate Data Analyses, supplied by Nonlinear Dynamics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/data+analyses/analyses+data+surrogate/pm42270777-110-19-17
    Average 86 stars, based on 1 article reviews
    surrogate data analyses - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Emmyon Inc data analyses
    Data Analyses, supplied by Emmyon Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/data+analyses/pm42117587-160-7-0
    Average 86 stars, based on 1 article reviews
    data analyses - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Novogene rna seq data analyses
    Generating a humanized stroma PDX (HS-PDX). A Tumor growth curves (i–iii) and (iv) summary of relative final tumor volumes of HS-PDXs with the indicate EC (combination iHUVEC/iHDMEC or EPC sources. TC + CA-MSC in the absence or presence of human EC (TC + CA-MSC; n = 6) (iHDMEC + iHUVEC) and Pt. EC/EPC (TC + CA-MSC + EC/EPC; n = 7). Tumor volumes in A (iv) are normalized TC + CA-MSC alone at 100%. B Representative IF evaluation of human tumor vascular antigen CD31 (red) in PDXs with the indicated EC/EPC sources. 4′,6-diamidino-2-phenylindole (DAPI; blue) was used to label cell nuclei. C IF evaluation of a tumor-specific vascular marker EGFL6 (red). Cell nuclei were counterstained with DAPI (blue). D <t>RNA-Seq-based</t> relative mRNA expression for two patient PDXs without and with the addition of human endothelial cells. E Growth curves for standard PDX and HS-PDX, derived from a patient with platinum refractory ovarian cancer, treated with carboplatin (blue arrows indicate timing of carboplatin administration ( n = 4–7/treatment group). Tumor volumes are internally normalized to the initial measurement for each tumor (~ 100 mm 3 ). Abbreviations : CA-MSC, cancer-associated mesenchymal stem cells; EC, endothelial cells; EPC, endothelial progenitor cells; iHDMEC, immortalized human dermal microvascular endothelial cells; iHUVEC, immortalized human umbilical vein endothelial cells; PDX, patient-derived xenograft; P0 and P1, passage 0 and passage 1. The first generation of PDX is denoted P0, and P0 is subsequently passaged to second generation (P1); Pt., patient; TC, tumor cells. * p < 0.05, ** p < 0.01, *** p < 0.001. Scale bars in B and C are 20 µm
    Rna Seq Data Analyses, supplied by Novogene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/data+analyses/data+rna+seq/pmc13013731-88-0-6
    Average 86 stars, based on 1 article reviews
    rna seq data analyses - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Optum Inc optum cdm data analyses
    Generating a humanized stroma PDX (HS-PDX). A Tumor growth curves (i–iii) and (iv) summary of relative final tumor volumes of HS-PDXs with the indicate EC (combination iHUVEC/iHDMEC or EPC sources. TC + CA-MSC in the absence or presence of human EC (TC + CA-MSC; n = 6) (iHDMEC + iHUVEC) and Pt. EC/EPC (TC + CA-MSC + EC/EPC; n = 7). Tumor volumes in A (iv) are normalized TC + CA-MSC alone at 100%. B Representative IF evaluation of human tumor vascular antigen CD31 (red) in PDXs with the indicated EC/EPC sources. 4′,6-diamidino-2-phenylindole (DAPI; blue) was used to label cell nuclei. C IF evaluation of a tumor-specific vascular marker EGFL6 (red). Cell nuclei were counterstained with DAPI (blue). D <t>RNA-Seq-based</t> relative mRNA expression for two patient PDXs without and with the addition of human endothelial cells. E Growth curves for standard PDX and HS-PDX, derived from a patient with platinum refractory ovarian cancer, treated with carboplatin (blue arrows indicate timing of carboplatin administration ( n = 4–7/treatment group). Tumor volumes are internally normalized to the initial measurement for each tumor (~ 100 mm 3 ). Abbreviations : CA-MSC, cancer-associated mesenchymal stem cells; EC, endothelial cells; EPC, endothelial progenitor cells; iHDMEC, immortalized human dermal microvascular endothelial cells; iHUVEC, immortalized human umbilical vein endothelial cells; PDX, patient-derived xenograft; P0 and P1, passage 0 and passage 1. The first generation of PDX is denoted P0, and P0 is subsequently passaged to second generation (P1); Pt., patient; TC, tumor cells. * p < 0.05, ** p < 0.01, *** p < 0.001. Scale bars in B and C are 20 µm
    Optum Cdm Data Analyses, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/data+analyses/analyses+cdm+data+optum/pm41508706-76-17-17
    Average 86 stars, based on 1 article reviews
    optum cdm data analyses - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    99
    Rigaku Corporation powder x ray diffraction pxrd data analyses
    Generating a humanized stroma PDX (HS-PDX). A Tumor growth curves (i–iii) and (iv) summary of relative final tumor volumes of HS-PDXs with the indicate EC (combination iHUVEC/iHDMEC or EPC sources. TC + CA-MSC in the absence or presence of human EC (TC + CA-MSC; n = 6) (iHDMEC + iHUVEC) and Pt. EC/EPC (TC + CA-MSC + EC/EPC; n = 7). Tumor volumes in A (iv) are normalized TC + CA-MSC alone at 100%. B Representative IF evaluation of human tumor vascular antigen CD31 (red) in PDXs with the indicated EC/EPC sources. 4′,6-diamidino-2-phenylindole (DAPI; blue) was used to label cell nuclei. C IF evaluation of a tumor-specific vascular marker EGFL6 (red). Cell nuclei were counterstained with DAPI (blue). D <t>RNA-Seq-based</t> relative mRNA expression for two patient PDXs without and with the addition of human endothelial cells. E Growth curves for standard PDX and HS-PDX, derived from a patient with platinum refractory ovarian cancer, treated with carboplatin (blue arrows indicate timing of carboplatin administration ( n = 4–7/treatment group). Tumor volumes are internally normalized to the initial measurement for each tumor (~ 100 mm 3 ). Abbreviations : CA-MSC, cancer-associated mesenchymal stem cells; EC, endothelial cells; EPC, endothelial progenitor cells; iHDMEC, immortalized human dermal microvascular endothelial cells; iHUVEC, immortalized human umbilical vein endothelial cells; PDX, patient-derived xenograft; P0 and P1, passage 0 and passage 1. The first generation of PDX is denoted P0, and P0 is subsequently passaged to second generation (P1); Pt., patient; TC, tumor cells. * p < 0.05, ** p < 0.01, *** p < 0.001. Scale bars in B and C are 20 µm
    Powder X Ray Diffraction Pxrd Data Analyses, supplied by Rigaku Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/data+analyses/MiniFlex/pmc13006799-41-0-10
    Average 99 stars, based on 1 article reviews
    powder x ray diffraction pxrd data analyses - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    86
    Biotechnology Information bioinformatic analyses 248 transcriptomic data
    Generating a humanized stroma PDX (HS-PDX). A Tumor growth curves (i–iii) and (iv) summary of relative final tumor volumes of HS-PDXs with the indicate EC (combination iHUVEC/iHDMEC or EPC sources. TC + CA-MSC in the absence or presence of human EC (TC + CA-MSC; n = 6) (iHDMEC + iHUVEC) and Pt. EC/EPC (TC + CA-MSC + EC/EPC; n = 7). Tumor volumes in A (iv) are normalized TC + CA-MSC alone at 100%. B Representative IF evaluation of human tumor vascular antigen CD31 (red) in PDXs with the indicated EC/EPC sources. 4′,6-diamidino-2-phenylindole (DAPI; blue) was used to label cell nuclei. C IF evaluation of a tumor-specific vascular marker EGFL6 (red). Cell nuclei were counterstained with DAPI (blue). D <t>RNA-Seq-based</t> relative mRNA expression for two patient PDXs without and with the addition of human endothelial cells. E Growth curves for standard PDX and HS-PDX, derived from a patient with platinum refractory ovarian cancer, treated with carboplatin (blue arrows indicate timing of carboplatin administration ( n = 4–7/treatment group). Tumor volumes are internally normalized to the initial measurement for each tumor (~ 100 mm 3 ). Abbreviations : CA-MSC, cancer-associated mesenchymal stem cells; EC, endothelial cells; EPC, endothelial progenitor cells; iHDMEC, immortalized human dermal microvascular endothelial cells; iHUVEC, immortalized human umbilical vein endothelial cells; PDX, patient-derived xenograft; P0 and P1, passage 0 and passage 1. The first generation of PDX is denoted P0, and P0 is subsequently passaged to second generation (P1); Pt., patient; TC, tumor cells. * p < 0.05, ** p < 0.01, *** p < 0.001. Scale bars in B and C are 20 µm
    Bioinformatic Analyses 248 Transcriptomic Data, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/data+analyses/data+rna+seq+%E2%80%A2/pm41578270-104-2-15
    Average 86 stars, based on 1 article reviews
    bioinformatic analyses 248 transcriptomic data - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    96
    MathWorks Inc data analyses
    Generating a humanized stroma PDX (HS-PDX). A Tumor growth curves (i–iii) and (iv) summary of relative final tumor volumes of HS-PDXs with the indicate EC (combination iHUVEC/iHDMEC or EPC sources. TC + CA-MSC in the absence or presence of human EC (TC + CA-MSC; n = 6) (iHDMEC + iHUVEC) and Pt. EC/EPC (TC + CA-MSC + EC/EPC; n = 7). Tumor volumes in A (iv) are normalized TC + CA-MSC alone at 100%. B Representative IF evaluation of human tumor vascular antigen CD31 (red) in PDXs with the indicated EC/EPC sources. 4′,6-diamidino-2-phenylindole (DAPI; blue) was used to label cell nuclei. C IF evaluation of a tumor-specific vascular marker EGFL6 (red). Cell nuclei were counterstained with DAPI (blue). D <t>RNA-Seq-based</t> relative mRNA expression for two patient PDXs without and with the addition of human endothelial cells. E Growth curves for standard PDX and HS-PDX, derived from a patient with platinum refractory ovarian cancer, treated with carboplatin (blue arrows indicate timing of carboplatin administration ( n = 4–7/treatment group). Tumor volumes are internally normalized to the initial measurement for each tumor (~ 100 mm 3 ). Abbreviations : CA-MSC, cancer-associated mesenchymal stem cells; EC, endothelial cells; EPC, endothelial progenitor cells; iHDMEC, immortalized human dermal microvascular endothelial cells; iHUVEC, immortalized human umbilical vein endothelial cells; PDX, patient-derived xenograft; P0 and P1, passage 0 and passage 1. The first generation of PDX is denoted P0, and P0 is subsequently passaged to second generation (P1); Pt., patient; TC, tumor cells. * p < 0.05, ** p < 0.01, *** p < 0.001. Scale bars in B and C are 20 µm
    Data Analyses, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/data+analyses/Database+Toolbox/pm41500090-88-4-9
    Average 96 stars, based on 1 article reviews
    data analyses - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    86
    Tree Star Inc data analyses
    Generating a humanized stroma PDX (HS-PDX). A Tumor growth curves (i–iii) and (iv) summary of relative final tumor volumes of HS-PDXs with the indicate EC (combination iHUVEC/iHDMEC or EPC sources. TC + CA-MSC in the absence or presence of human EC (TC + CA-MSC; n = 6) (iHDMEC + iHUVEC) and Pt. EC/EPC (TC + CA-MSC + EC/EPC; n = 7). Tumor volumes in A (iv) are normalized TC + CA-MSC alone at 100%. B Representative IF evaluation of human tumor vascular antigen CD31 (red) in PDXs with the indicated EC/EPC sources. 4′,6-diamidino-2-phenylindole (DAPI; blue) was used to label cell nuclei. C IF evaluation of a tumor-specific vascular marker EGFL6 (red). Cell nuclei were counterstained with DAPI (blue). D <t>RNA-Seq-based</t> relative mRNA expression for two patient PDXs without and with the addition of human endothelial cells. E Growth curves for standard PDX and HS-PDX, derived from a patient with platinum refractory ovarian cancer, treated with carboplatin (blue arrows indicate timing of carboplatin administration ( n = 4–7/treatment group). Tumor volumes are internally normalized to the initial measurement for each tumor (~ 100 mm 3 ). Abbreviations : CA-MSC, cancer-associated mesenchymal stem cells; EC, endothelial cells; EPC, endothelial progenitor cells; iHDMEC, immortalized human dermal microvascular endothelial cells; iHUVEC, immortalized human umbilical vein endothelial cells; PDX, patient-derived xenograft; P0 and P1, passage 0 and passage 1. The first generation of PDX is denoted P0, and P0 is subsequently passaged to second generation (P1); Pt., patient; TC, tumor cells. * p < 0.05, ** p < 0.01, *** p < 0.001. Scale bars in B and C are 20 µm
    Data Analyses, supplied by Tree Star Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/data+analyses/analyses+data/pm41314617-57-0-9
    Average 86 stars, based on 1 article reviews
    data analyses - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Novogene data analyses
    Generating a humanized stroma PDX (HS-PDX). A Tumor growth curves (i–iii) and (iv) summary of relative final tumor volumes of HS-PDXs with the indicate EC (combination iHUVEC/iHDMEC or EPC sources. TC + CA-MSC in the absence or presence of human EC (TC + CA-MSC; n = 6) (iHDMEC + iHUVEC) and Pt. EC/EPC (TC + CA-MSC + EC/EPC; n = 7). Tumor volumes in A (iv) are normalized TC + CA-MSC alone at 100%. B Representative IF evaluation of human tumor vascular antigen CD31 (red) in PDXs with the indicated EC/EPC sources. 4′,6-diamidino-2-phenylindole (DAPI; blue) was used to label cell nuclei. C IF evaluation of a tumor-specific vascular marker EGFL6 (red). Cell nuclei were counterstained with DAPI (blue). D <t>RNA-Seq-based</t> relative mRNA expression for two patient PDXs without and with the addition of human endothelial cells. E Growth curves for standard PDX and HS-PDX, derived from a patient with platinum refractory ovarian cancer, treated with carboplatin (blue arrows indicate timing of carboplatin administration ( n = 4–7/treatment group). Tumor volumes are internally normalized to the initial measurement for each tumor (~ 100 mm 3 ). Abbreviations : CA-MSC, cancer-associated mesenchymal stem cells; EC, endothelial cells; EPC, endothelial progenitor cells; iHDMEC, immortalized human dermal microvascular endothelial cells; iHUVEC, immortalized human umbilical vein endothelial cells; PDX, patient-derived xenograft; P0 and P1, passage 0 and passage 1. The first generation of PDX is denoted P0, and P0 is subsequently passaged to second generation (P1); Pt., patient; TC, tumor cells. * p < 0.05, ** p < 0.01, *** p < 0.001. Scale bars in B and C are 20 µm
    Data Analyses, supplied by Novogene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/data+analyses/analyses+data/pmc12678372-97-3-10
    Average 86 stars, based on 1 article reviews
    data analyses - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    Image Search Results


    Generating a humanized stroma PDX (HS-PDX). A Tumor growth curves (i–iii) and (iv) summary of relative final tumor volumes of HS-PDXs with the indicate EC (combination iHUVEC/iHDMEC or EPC sources. TC + CA-MSC in the absence or presence of human EC (TC + CA-MSC; n = 6) (iHDMEC + iHUVEC) and Pt. EC/EPC (TC + CA-MSC + EC/EPC; n = 7). Tumor volumes in A (iv) are normalized TC + CA-MSC alone at 100%. B Representative IF evaluation of human tumor vascular antigen CD31 (red) in PDXs with the indicated EC/EPC sources. 4′,6-diamidino-2-phenylindole (DAPI; blue) was used to label cell nuclei. C IF evaluation of a tumor-specific vascular marker EGFL6 (red). Cell nuclei were counterstained with DAPI (blue). D RNA-Seq-based relative mRNA expression for two patient PDXs without and with the addition of human endothelial cells. E Growth curves for standard PDX and HS-PDX, derived from a patient with platinum refractory ovarian cancer, treated with carboplatin (blue arrows indicate timing of carboplatin administration ( n = 4–7/treatment group). Tumor volumes are internally normalized to the initial measurement for each tumor (~ 100 mm 3 ). Abbreviations : CA-MSC, cancer-associated mesenchymal stem cells; EC, endothelial cells; EPC, endothelial progenitor cells; iHDMEC, immortalized human dermal microvascular endothelial cells; iHUVEC, immortalized human umbilical vein endothelial cells; PDX, patient-derived xenograft; P0 and P1, passage 0 and passage 1. The first generation of PDX is denoted P0, and P0 is subsequently passaged to second generation (P1); Pt., patient; TC, tumor cells. * p < 0.05, ** p < 0.01, *** p < 0.001. Scale bars in B and C are 20 µm

    Journal: Cancer Immunology, Immunotherapy : CII

    Article Title: A novel humanized immune stroma PDX cancer model for therapeutic studies

    doi: 10.1007/s00262-026-04349-4

    Figure Lengend Snippet: Generating a humanized stroma PDX (HS-PDX). A Tumor growth curves (i–iii) and (iv) summary of relative final tumor volumes of HS-PDXs with the indicate EC (combination iHUVEC/iHDMEC or EPC sources. TC + CA-MSC in the absence or presence of human EC (TC + CA-MSC; n = 6) (iHDMEC + iHUVEC) and Pt. EC/EPC (TC + CA-MSC + EC/EPC; n = 7). Tumor volumes in A (iv) are normalized TC + CA-MSC alone at 100%. B Representative IF evaluation of human tumor vascular antigen CD31 (red) in PDXs with the indicated EC/EPC sources. 4′,6-diamidino-2-phenylindole (DAPI; blue) was used to label cell nuclei. C IF evaluation of a tumor-specific vascular marker EGFL6 (red). Cell nuclei were counterstained with DAPI (blue). D RNA-Seq-based relative mRNA expression for two patient PDXs without and with the addition of human endothelial cells. E Growth curves for standard PDX and HS-PDX, derived from a patient with platinum refractory ovarian cancer, treated with carboplatin (blue arrows indicate timing of carboplatin administration ( n = 4–7/treatment group). Tumor volumes are internally normalized to the initial measurement for each tumor (~ 100 mm 3 ). Abbreviations : CA-MSC, cancer-associated mesenchymal stem cells; EC, endothelial cells; EPC, endothelial progenitor cells; iHDMEC, immortalized human dermal microvascular endothelial cells; iHUVEC, immortalized human umbilical vein endothelial cells; PDX, patient-derived xenograft; P0 and P1, passage 0 and passage 1. The first generation of PDX is denoted P0, and P0 is subsequently passaged to second generation (P1); Pt., patient; TC, tumor cells. * p < 0.05, ** p < 0.01, *** p < 0.001. Scale bars in B and C are 20 µm

    Article Snippet: RNA-seq data analyses were performed by Novogene and Dr. Hui Shen’s research group.

    Techniques: Marker, RNA Sequencing, Expressing, Derivative Assay

    Identifying the optimal humanized bone marrow mouse type for the humanized immune stroma PDX (HIS-PDX). PDX models established in immunodeficient NSG, humanized HuNSG-SGM3 and humanized BLT mice were named as NSG-PDX, HuSGM3-PDX and BLT-PDX models, respectively. A-C RNA-seq-based mRNA analysis of the indicated lymphocyte ( A ), myeloid cell ( B ) and NK cell ( C ) markers genes in NSG-PDX, HuSGM3-PDX and BLT-PDX tumors. Expression is normalized using the expression in matched primary patient-derived tumor. D IF for human CD3, CD8, CD14 and CD163 evaluating tumor immune infiltrates in the indicated PDX tumor models. Cell nuclei were counterstained with DAPI (blue). Scale bars, 20 µm

    Journal: Cancer Immunology, Immunotherapy : CII

    Article Title: A novel humanized immune stroma PDX cancer model for therapeutic studies

    doi: 10.1007/s00262-026-04349-4

    Figure Lengend Snippet: Identifying the optimal humanized bone marrow mouse type for the humanized immune stroma PDX (HIS-PDX). PDX models established in immunodeficient NSG, humanized HuNSG-SGM3 and humanized BLT mice were named as NSG-PDX, HuSGM3-PDX and BLT-PDX models, respectively. A-C RNA-seq-based mRNA analysis of the indicated lymphocyte ( A ), myeloid cell ( B ) and NK cell ( C ) markers genes in NSG-PDX, HuSGM3-PDX and BLT-PDX tumors. Expression is normalized using the expression in matched primary patient-derived tumor. D IF for human CD3, CD8, CD14 and CD163 evaluating tumor immune infiltrates in the indicated PDX tumor models. Cell nuclei were counterstained with DAPI (blue). Scale bars, 20 µm

    Article Snippet: RNA-seq data analyses were performed by Novogene and Dr. Hui Shen’s research group.

    Techniques: RNA Sequencing, Expressing, Derivative Assay

    Analysis of complete humanized immune stroma PDX (HIS-PDX). HIS-PDX were created by co-engraftment of PDX TC, CA-MSC and EC (iHUVEC + iHDMEC). A IF for alpha smooth muscle actin (αSMA; red), and human-specific mitochondrial antigen (hMitoc; green) or pan-cytokeratin (PanCK; green) to label tumor cells in standard and HIS-PDX. Cell nuclei were counterstained with DAPI (blue) ( n = 3). B Hematoxylin and eosin (H&E) staining for a cell line-derived xenograft, standard PDX, humanized immune stroma PDX (HIS-PDX) and matched patient’s primary tumor ( n = 3). C RNA-seq derived heat map for stromal and immune gene expression in solid tumor-derived standard PDXs (StndPDX), HIS-PDX and patient primary tumor ( n = 3). D Total gene expression correlation between primary human tumor and primary tumor-derived HIS-PDX for patient 1 and patient 4. Scale bars in ( A ), 40 µm; scale bars in ( B ), 100 µm

    Journal: Cancer Immunology, Immunotherapy : CII

    Article Title: A novel humanized immune stroma PDX cancer model for therapeutic studies

    doi: 10.1007/s00262-026-04349-4

    Figure Lengend Snippet: Analysis of complete humanized immune stroma PDX (HIS-PDX). HIS-PDX were created by co-engraftment of PDX TC, CA-MSC and EC (iHUVEC + iHDMEC). A IF for alpha smooth muscle actin (αSMA; red), and human-specific mitochondrial antigen (hMitoc; green) or pan-cytokeratin (PanCK; green) to label tumor cells in standard and HIS-PDX. Cell nuclei were counterstained with DAPI (blue) ( n = 3). B Hematoxylin and eosin (H&E) staining for a cell line-derived xenograft, standard PDX, humanized immune stroma PDX (HIS-PDX) and matched patient’s primary tumor ( n = 3). C RNA-seq derived heat map for stromal and immune gene expression in solid tumor-derived standard PDXs (StndPDX), HIS-PDX and patient primary tumor ( n = 3). D Total gene expression correlation between primary human tumor and primary tumor-derived HIS-PDX for patient 1 and patient 4. Scale bars in ( A ), 40 µm; scale bars in ( B ), 100 µm

    Article Snippet: RNA-seq data analyses were performed by Novogene and Dr. Hui Shen’s research group.

    Techniques: Staining, Derivative Assay, RNA Sequencing, Gene Expression